H. Lundbeck A/s

This study looked at the long-term safety of eptinezumab, a medicine given as an infusion to prevent migraines. It included 160 Japanese adults who had already completed a previous study. The main goal was to see if the drug was safe and tolerable over 60 weeks of treatment.

This study tested whether adding eptinezumab (a migraine prevention drug) to a brief educational program helps adults with both migraine and medication overuse headache. Over 600 participants were followed to see if the drug reduced monthly migraine days, headache days, and the n…

This study tested a drug called eptinezumab to see if it could prevent migraines in people with chronic migraine. Nearly 1,000 adults with at least 8 migraine days per month took part. The main goal was to see if the drug reduced the number of monthly migraine days compared to a …

This early-stage study looked at whether a new drug called Lu AG09222 is safe to take together with the migraine medication ubrogepant. 43 adults with migraine received ubrogepant pills plus an injection of either Lu AG09222 or a placebo. The main goal was to track any side effec…

This early-stage study tested a new drug called Lu AF28996 in 57 people with Parkinson's disease. The main goal was to see if the drug is safe and how the body processes it. Researchers measured side effects and drug levels in the blood. This is a first step to see if the drug mi…